Showing results (61-70 of 1,520) with videos related to

Sort By:
Pageof 152
CPT: Pharmacometrics & Systems Pharmacology|September 23, 2016
Applied Concepts in PBPK Modeling: How to Build a PBPK/PD ModelL Kuepfer, C Niederalt, T Wendl, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 31, 2017
Population Modeling of Selexipag Pharmacokinetics and Clinical Response Parameters in Patients With Pulmonary Arterial HypertensionA Krause, M Machacek, D Lott, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 31, 2017
A Mathematical Model to Predict HIV Virological Failure and Elucidate the Role of Lymph Node Drug PenetrationS Sanche, N Sheehan, T Mesplède, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 2, 2017
Quantitative Modeling and Simulation in PMDA: A Japanese Regulatory PerspectiveM Sato, Y Ochiai, S Kijima, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 2, 2017
Exposure-Response Analysis of Necitumumab Efficacy in Squamous Non-Small Cell Lung Cancer PatientsE Chigutsa, A J Long, J E Wallin
CPT: Pharmacometrics & Systems Pharmacology|June 3, 2017
Supervised Machine-Learning Reveals That Old and Obese People Achieve Low Dapsone ConcentrationsR G Hall, J G Pasipanodya, M A Swancutt, et al.
CPT: Pharmacometrics & Systems Pharmacology|June 15, 2017
Determination of Plasma Concentration Reference Ranges for Risperidone and PaliperidoneJ Korell, B Green, B Remmerie, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 10, 2022
Advancing drug safety science by integrating molecular knowledge with post-marketing adverse event reportsTheodoros G Soldatos, Sarah Kim, Stephan Schmidt, et al.
CPT: Pharmacometrics & Systems Pharmacology|February 15, 2022
Model-informed drug development supporting the approval of the avelumab flat-dose regimen in patients with advanced renal cell carcinomaJoanna C Masters, Akash Khandelwal, Alessandra di Pietro, et al.
Pageof 152